Paloma Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,730
| Closed | -$293K | – | 346 |
|
|
2024
Q3 | $293K | Buy |
+14,730
| New | +$293K | 0.01% | 551 |
|
|
2019
Q4 | – | Sell |
-54,502
| Closed | -$289K | – | 1868 |
|
|
2019
Q3 | $289K | Buy |
+54,502
| New | +$289K | 0.01% | 1238 |
|
|
2019
Q1 | – | Sell |
-15,740
| Closed | -$30K | – | 1370 |
|
|
2018
Q4 | $30K | Buy |
+15,740
| New | +$30K | ﹤0.01% | 939 |
|
|
2016
Q3 | – | Sell |
-282,261
| Closed | -$200K | – | 1409 |
|
|
2016
Q2 | $200K | Buy |
+282,261
| New | +$200K | ﹤0.01% | 1534 |
|
|
2016
Q1 | – | Sell |
-20,372
| Closed | -$50K | – | 1480 |
|
|
2015
Q4 | $50K | Buy |
+20,372
| New | +$50K | ﹤0.01% | 1308 |
|
|
2014
Q4 | – | Sell |
-71,994
| Closed | -$239K | – | 1077 |
|
|
2014
Q3 | $239K | Buy |
+71,994
| New | +$239K | 0.01% | 727 |
|